Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Hudson Executive Investment (HEC) Competitors

Hudson Executive Investment logo

HEC vs. KDLY, BTTX, UPHL, SNDL, ERAS, DCTH, CMPX, AQST, EBS, and ITOS

Should you be buying Hudson Executive Investment stock or one of its competitors? The main competitors of Hudson Executive Investment include Kindly MD (KDLY), Better Therapeutics (BTTX), UpHealth (UPHL), SNDL (SNDL), Erasca (ERAS), Delcath Systems (DCTH), Compass Therapeutics (CMPX), Aquestive Therapeutics (AQST), Emergent Biosolutions (EBS), and iTeos Therapeutics (ITOS). These companies are all part of the "medical" sector.

Hudson Executive Investment vs. Its Competitors

Hudson Executive Investment (NASDAQ:HEC) and Kindly MD (NASDAQ:KDLY) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, risk, profitability, institutional ownership, valuation, analyst recommendations and media sentiment.

73.4% of Hudson Executive Investment shares are owned by institutional investors. 50.5% of Kindly MD shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Kindly MD has higher revenue and earnings than Hudson Executive Investment.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hudson Executive InvestmentN/AN/A-$27.24MN/AN/A
Kindly MD$2.47M26.69-$4.64M-$0.77-14.22

Kindly MD's return on equity of 0.00% beat Hudson Executive Investment's return on equity.

Company Net Margins Return on Equity Return on Assets
Hudson Executive InvestmentN/A -337.48% -4.06%
Kindly MD N/A N/A N/A

In the previous week, Kindly MD had 1 more articles in the media than Hudson Executive Investment. MarketBeat recorded 1 mentions for Kindly MD and 0 mentions for Hudson Executive Investment. Kindly MD's average media sentiment score of 1.10 beat Hudson Executive Investment's score of 0.00 indicating that Kindly MD is being referred to more favorably in the news media.

Company Overall Sentiment
Hudson Executive Investment Neutral
Kindly MD Positive

Summary

Kindly MD beats Hudson Executive Investment on 7 of the 8 factors compared between the two stocks.

Get Hudson Executive Investment News Delivered to You Automatically

Sign up to receive the latest news and ratings for HEC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HEC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HEC vs. The Competition

MetricHudson Executive InvestmentHealth Services IndustryMedical SectorNASDAQ Exchange
Market Cap$107.64M$71.21M$5.49B$9.45B
Dividend YieldN/AN/A4.01%4.03%
P/E RatioN/AN/A28.4719.90
Price / SalesN/A9.69410.1985.18
Price / CashN/A4.0235.9658.29
Price / Book21.671.158.365.67
Net Income-$27.24M-$30.80M$3.24B$258.18M

Hudson Executive Investment Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HEC
Hudson Executive Investment
N/A$2.60
+2.0%
N/A+19.2%$107.64MN/A0.00N/A
KDLY
Kindly MD
N/A$12.09
-1.7%
N/A+266.2%$72.81M$2.47M-15.70N/APositive News
BTTX
Better Therapeutics
N/A$0.00
flat
N/AN/A$5KN/A0.0040
UPHL
UpHealth
N/A$0.00
flat
N/A-99.9%$4K$130M0.001,750
SNDL
SNDL
1.2778 of 5 stars
$1.51
-4.4%
$3.63
+140.1%
-27.8%$415.19M$671.81M-5.212,516
ERAS
Erasca
2.1571 of 5 stars
$1.41
-3.4%
$4.57
+224.2%
-46.5%$413.60MN/A-2.27120
DCTH
Delcath Systems
2.1518 of 5 stars
$11.02
-7.2%
$24.00
+117.8%
+33.2%$413.39M$37.21M-22.0460News Coverage
High Trading Volume
CMPX
Compass Therapeutics
2.2876 of 5 stars
$2.98
+2.1%
$12.67
+325.1%
+207.0%$403.79M$850K-7.2720
AQST
Aquestive Therapeutics
1.3036 of 5 stars
$4.02
-0.2%
$10.14
+152.3%
+31.0%$400.29M$54.23M-6.81160
EBS
Emergent Biosolutions
3.9109 of 5 stars
$6.94
-5.0%
$14.33
+106.6%
-37.6%$396.23M$1.04B-2.562,420
ITOS
iTeos Therapeutics
3.4292 of 5 stars
$10.31
-0.4%
$15.86
+53.8%
-38.7%$396.13M$35M-3.3990Trending News
Analyst Forecast

Related Companies and Tools


This page (NASDAQ:HEC) was last updated on 7/23/2025 by MarketBeat.com Staff
From Our Partners